Sigma Healthcare Limited (ASX:SIG)
Australia · Delayed Price · Currency is AUD 2.640
+0.020 (0.76%)
Oct 7, 2026, 4:11 PM AEST
Sigma Healthcare Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 30,367 | 31,631 | 34,516 | 2,081 | 890 | 614 | |
Market Cap Growth | -11.69% | -8.36% | 1558.90% | 133.83% | 44.83% | -2.52% |
Enterprise Value | 32,250 | 33,467 | 35,551 | 3,049 | 1,899 | 2,353 |
Last Close Price | 2.64 | 2.73 | 2.93 | 1.25 | 0.79 | 0.54 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 42.82 | 44.60 | 65.13 | 3.85 | 2.92 | 1.59 |
Forward PE | 34.99 | 37.36 | 50.68 | - | - | - |
PS Ratio | 2.80 | 2.92 | 5.75 | 0.63 | 0.29 | 0.21 |
PB Ratio | 6.09 | 6.34 | 7.41 | 2.90 | 2.34 | 1.77 |
P/TBV Ratio | 26.54 | 27.64 | 42.61 | 2.93 | 2.35 | 1.79 |
P/FCF Ratio | 58.63 | 61.07 | 63.19 | 8.66 | 2.06 | 2.27 |
P/OCF Ratio | 52.85 | 55.05 | 57.64 | 7.62 | 2.00 | 2.16 |
PEG Ratio | 1.97 | 1.74 | 8.34 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 2.98 | 3.09 | 5.92 | 0.93 | 0.61 | 0.79 |
EV/EBITDA Ratio | 28.92 | 32.24 | 47.31 | 5.36 | 4.32 | 4.02 |
EV/EBIT Ratio | 31.31 | 33.74 | 49.20 | 5.52 | 4.43 | 4.10 |
EV/FCF Ratio | 62.27 | 64.62 | 65.08 | 12.69 | 4.39 | 8.67 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.41 | 0.41 | 0.44 | 1.83 | 3.10 | 3.22 |
Debt / EBITDA Ratio | 1.88 | 1.88 | 2.66 | 2.23 | 2.25 | 1.57 |
Debt / FCF Ratio | 3.90 | 3.90 | 3.79 | 5.47 | 2.73 | 4.12 |
Net Debt / Equity Ratio | 0.38 | 0.38 | 0.42 | 1.45 | 2.56 | 2.91 |
Net Debt / EBITDA Ratio | 1.82 | 1.82 | 2.57 | 1.83 | 2.21 | 1.73 |
Net Debt / FCF Ratio | 3.65 | 3.65 | 3.54 | 4.33 | 2.25 | 3.73 |
Asset Turnover | 1.26 | 1.26 | 1.08 | 1.29 | 1.41 | 1.21 |
Inventory Turnover | 7.84 | 7.84 | 5.63 | 4.16 | 4.46 | 4.26 |
Quick Ratio | 1.04 | 1.04 | 1.09 | 1.13 | 0.90 | 0.83 |
Current Ratio | 1.67 | 1.67 | 1.71 | 1.79 | 1.54 | 1.50 |
Return on Equity (ROE) | 14.69% | 14.69% | 19.54% | 98.42% | 83.22% | 176.49% |
Return on Assets (ROA) | 7.21% | 7.21% | 8.10% | 13.56% | 12.24% | 14.52% |
Return on Invested Capital (ROIC) | 10.17% | 10.38% | 12.23% | 33.42% | 22.29% | 35.21% |
Return on Capital Employed (ROCE) | 14.50% | 14.50% | 11.00% | 29.00% | 30.00% | 41.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 2.34% | 2.24% | 1.54% | 26.00% | 34.20% | 62.82% |
FCF Yield | 1.71% | 1.64% | 1.58% | 11.55% | 48.60% | 44.16% |
Dividend Yield | 1.51% | 1.47% | 0.44% | - | - | - |
Payout Ratio | 53.42% | 53.42% | 91.72% | 40.24% | 86.77% | 69.77% |
Buyback Yield / Dilution | -9.78% | -9.78% | -6.70% | -532.62% | - | -0.13% |
Total Shareholder Return | -8.26% | -8.31% | -6.26% | -532.62% | - | -0.13% |